CGON
CG Oncology, Inc.
$69.20
-0.06 (-0.09%)
At close · Jul 7
Market Cap
$6.10B
Shares
88,202,473
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$4.04M
+254.7%
FY2025
Net Income
-$161M
-82.9%
FY2025
Operating Margin
-4722.13%
+5345.1pp
FY2025
Diluted EPS
-$2.08
-47.5%
FY2025
Operating Cash Flow
-$132.35M
-68.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $5.07M | $4.04M | $1.14M | $204K | |
| $132.9M | $116.64M | $82.1M | $45.75M | |
| $79.52M | $73.53M | $33.7M | $9.9M | |
| — | $1.45M | $32K | $17K | |
| $157.84M | — | $115.81M | $55.65M | |
| -$214.96M | -$190.77M | -$114.67M | -$55.45M | |
| — | -4722.13% | -10067.25% | -27180.88% | |
| — | -$189.33M | -$114.63M | -$55.43M | |
| $28.47M | $29.93M | $26.62M | $6.9M | |
| $28.21M | $29.78M | $26.63M | $6.84M | |
| — | -$270K | $1000 | $1000 | |
| -$186.75M | -$161M | -$88.04M | -$48.61M | |
| — | -3985.02% | -7729.5% | -23826.96% | |
| — | -$161M | -$88.04M | -$67.8M | |
| USD/shares | — | -$2.08 | -$1.41 | -$15.65 |
| USD/shares | — | -$2.08 | -$1.41 | -$15.65 |
| shares | — | 77.3M | 62.5M | 4.33M |
| shares | — | 77.3M | 62.5M | 4.33M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Commercial and Development Revenue | $3,234,000 | $0 | $0 |
| License and Collaboration Revenue | $806,000 | $1,139,000 | $204,000 |